Cargando…
canSAR: an integrated cancer public translational research and drug discovery resource
canSAR is a fully integrated cancer research and drug discovery resource developed to utilize the growing publicly available biological annotation, chemical screening, RNA interference screening, expression, amplification and 3D structural data. Scientists can, in a single place, rapidly identify bi...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3245005/ https://www.ncbi.nlm.nih.gov/pubmed/22013161 http://dx.doi.org/10.1093/nar/gkr881 |
_version_ | 1782219778178416640 |
---|---|
author | Halling-Brown, Mark D. Bulusu, Krishna C. Patel, Mishal Tym, Joe E. Al-Lazikani, Bissan |
author_facet | Halling-Brown, Mark D. Bulusu, Krishna C. Patel, Mishal Tym, Joe E. Al-Lazikani, Bissan |
author_sort | Halling-Brown, Mark D. |
collection | PubMed |
description | canSAR is a fully integrated cancer research and drug discovery resource developed to utilize the growing publicly available biological annotation, chemical screening, RNA interference screening, expression, amplification and 3D structural data. Scientists can, in a single place, rapidly identify biological annotation of a target, its structural characterization, expression levels and protein interaction data, as well as suitable cell lines for experiments, potential tool compounds and similarity to known drug targets. canSAR has, from the outset, been completely use-case driven which has dramatically influenced the design of the back-end and the functionality provided through the interfaces. The Web interface at http://cansar.icr.ac.uk provides flexible, multipoint entry into canSAR. This allows easy access to the multidisciplinary data within, including target and compound synopses, bioactivity views and expert tools for chemogenomic, expression and protein interaction network data. |
format | Online Article Text |
id | pubmed-3245005 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-32450052012-01-10 canSAR: an integrated cancer public translational research and drug discovery resource Halling-Brown, Mark D. Bulusu, Krishna C. Patel, Mishal Tym, Joe E. Al-Lazikani, Bissan Nucleic Acids Res Articles canSAR is a fully integrated cancer research and drug discovery resource developed to utilize the growing publicly available biological annotation, chemical screening, RNA interference screening, expression, amplification and 3D structural data. Scientists can, in a single place, rapidly identify biological annotation of a target, its structural characterization, expression levels and protein interaction data, as well as suitable cell lines for experiments, potential tool compounds and similarity to known drug targets. canSAR has, from the outset, been completely use-case driven which has dramatically influenced the design of the back-end and the functionality provided through the interfaces. The Web interface at http://cansar.icr.ac.uk provides flexible, multipoint entry into canSAR. This allows easy access to the multidisciplinary data within, including target and compound synopses, bioactivity views and expert tools for chemogenomic, expression and protein interaction network data. Oxford University Press 2012-01 2011-10-19 /pmc/articles/PMC3245005/ /pubmed/22013161 http://dx.doi.org/10.1093/nar/gkr881 Text en © The Author(s) 2011. Published by Oxford University Press. http://creativecommons.org/licenses/by-nc/3.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Articles Halling-Brown, Mark D. Bulusu, Krishna C. Patel, Mishal Tym, Joe E. Al-Lazikani, Bissan canSAR: an integrated cancer public translational research and drug discovery resource |
title | canSAR: an integrated cancer public translational research and drug discovery resource |
title_full | canSAR: an integrated cancer public translational research and drug discovery resource |
title_fullStr | canSAR: an integrated cancer public translational research and drug discovery resource |
title_full_unstemmed | canSAR: an integrated cancer public translational research and drug discovery resource |
title_short | canSAR: an integrated cancer public translational research and drug discovery resource |
title_sort | cansar: an integrated cancer public translational research and drug discovery resource |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3245005/ https://www.ncbi.nlm.nih.gov/pubmed/22013161 http://dx.doi.org/10.1093/nar/gkr881 |
work_keys_str_mv | AT hallingbrownmarkd cansaranintegratedcancerpublictranslationalresearchanddrugdiscoveryresource AT bulusukrishnac cansaranintegratedcancerpublictranslationalresearchanddrugdiscoveryresource AT patelmishal cansaranintegratedcancerpublictranslationalresearchanddrugdiscoveryresource AT tymjoee cansaranintegratedcancerpublictranslationalresearchanddrugdiscoveryresource AT allazikanibissan cansaranintegratedcancerpublictranslationalresearchanddrugdiscoveryresource |